Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression-Reference-Cited by-同舟云学术

Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression

Published:2005-06 Issue:1 Volume:224 Page:53-65
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Notarbartolo Monica,Poma Paola,Perri Daniela,Dusonchet Luisa,Cervello Melchiorre,D'Alessandro Natale

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference40 articles.

1. Primary liver cancer;Falkson;Cancer,1994

2. Survivin promotes cell proliferation in human hepatocellular carcinoma;Ito;Hepatology,2000

3. Expression and role of Bcl-xL in human hepatocellular carcinomas;Takehara;Hepatology,2001

4. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma;Ikeguchi;Cancer,2002

5. Overexpression of X-linked inhibitor of apoptosis in human hepatocellular carcinoma;Shiraki;Int. J. Mol. Med.,2003

Cited by 275 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study on curcumin fortification to improve the physicochemical properties and anti-oxidative potentialities of butteroil (ghee);Food and Humanity;2024-12

2. The Bright Side of Curcumin: A Narrative Review of Its Therapeutic Potential in Cancer Management;Cancers;2024-07-18

3. Tomatidine, a Steroidal Alkaloid, Synergizes with Cisplatin to Inhibit Cell Viability and Induce Cell Death Selectively on FLT3-ITD+ Acute Myeloid Leukemia Cells;Cell Biochemistry and Biophysics;2024-07-11

4. Anti-inflammatory and anti-cancer potential of pterostilbene: A review;Asian Pacific Journal of Tropical Biomedicine;2023-12

5. Curcuminoids as Anticancer Drugs: Pleiotropic Effects, Potential for Metabolic Reprogramming and Prospects for the Future;Pharmaceutics;2023-05-29